| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |